Skip to main content
Infectious Disease Modelling logoLink to Infectious Disease Modelling
. 2022 Nov 30;8(1):27–57. doi: 10.1016/j.idm.2022.11.010

Understanding the transmission pathways of Lassa fever: A mathematical modeling approach

Praise-God Uchechukwu Madueme 1, Faraimunashe Chirove 1,
PMCID: PMC9762202  PMID: 36582748

Abstract

The spread of Lassa fever infection is increasing in West Africa over the last decade. The impact of this can better be understood when considering the various possible transmission routes. We designed a mathematical model for the epidemiology of Lassa Fever using a system of nonlinear ordinary differential equations to determine the effect of transmission pathways toward the infection progression in humans and rodents including those usually neglected such as the environmental surface and aerosol routes. We analyzed the model and carried out numerical simulations to determine the impact of each transmission routes. Our results showed that the burden of Lassa fever infection is increased when all the transmission routes are incorporated and most single transmission routes are less harmful, but when in combination with other transmission routes, they increase the Lassa fever burden. It is therefore important to consider multiple transmission routes to better estimate the Lassa fever burden optimally and in turn determine control strategies targeted at the transmission pathways.

Keywords: Transmission, Dynamics, Mastomys, Lassa fever

1. Introduction

Lassa fever (LF) is an acute viral zoonotic illness responsible for a severe hemorrhagic fever. It is an illness caused by Lassa virus which is a single-stranded RNA virus from the arenavirus family. It was first discovered in 1969 in a Nigerian town called Lassa in Borno State when two missionary nurses died from the illness (Richmond & Baglole, 2003). The animal vector of this virus is the multimammate rat (Mastomys natalensis) which is one of the most common rodents in West Africa (CDC, 2014; Gonzalez, 2020; NICD, 2020). The Mastomys rodents reproduce often and excrete the virus in urine for a very long period of time, and because they occupy human homes, especially where food is stored, they help spread the virus to humans. The transmission of this virus to humans can be through direct or indirect contact. Direct transmissions result from contact between humans and humans, rodents and humans, and rodents and rodents. The evidence available shows that human to human transmission occurs through contact with the body fluids, secretions, excretions, blood of the infectious individual, and sexual transmission (Newman, 2018; NICD, 2020). The infected Mastomys rodents are caught (as bush meat) and eaten as food in certain places which directly infects the individuals with the virus. Reports have also shown that there is both horizontal and vertical transmission in multimammate rats especially in seasons when these rodents are actively breeding (Fichet-Calvet et al., 2014; Tewogbola & Aung, ; Gibb et al., 2017). In this paper, however, vertical transmission from rodent to rodent is not covered. Rodents can deposit the virus through their urine and faeces on surfaces in the households such as walls and places where food is stored or even on surfaces where medical equipment is kept. Humans can indirectly acquire the virus when they come in contact with the virus on these contaminated surfaces. Rodents can also become infected because rats share garbage, food on surfaces contaminated with the excretions of infectious rodents yet do not die due to disease but carry the infection and continue to shed it throughout their lifetime (NICD, 2020; Obabiyi & Onifade, 2017). Another form of indirect transmission is through airborne (aerosol) transmission which occurs especially in health centres when people inhale air particles contaminated with the droppings of infected rodents especially during activities like sweeping and other wind activities (CDC, 2014; Gonzalez, 2020; NICD, 2020). The natural history of Lassa fever reveals that its transmission pattern is driven by the frequency of exposure to infected individuals or through contact with infected rodents and contaminated environments (Akhmetzhanov et al., 2019; Sabeti, 2015). It has been shown that Lassa virus is stable as an aerosol, particularly at low relative humidity (30% RH) and the biological half-life at both 24 °C and 32 °C ranges from 10.1 to 54.6 min (CDC, 2014; Stephenson et al., 1984).

Frequent cases of Lassa virus infection have been seen in endemic regions such as Nigeria, Benin, Ghana, Guinea, Liberia, Mali, Sierra Leone and Togo. Surrounding regions like Central African Republic, Burkina Faso, Côte d’Ivoire, Mali, Senegal, Ghana among others are also at risk, because the rodents that transmit the virus are very common throughout West and East Africa. Hospital staff are also at risk for infection especially in areas with inadequate protective measures and improper sterilization methods (Gibb et al., 2017; NICD, 2020; WHO, 2017). After contracting the virus, humans show symptoms between 1 and 3 weeks. The presence of virus in the blood is known to peak four to nine days after the onset of symptoms. In most cases, 80% of people infected show no observable or mild symptoms. For these individuals, they show mild signs like slight fever, general malaise and weakness, and headache but do not die due to the infection. Recovery can take place eight to ten days after inception. The remaining 20% of infected individuals can show more severe symptoms like bleeding in the gums, eyes, or nose, respiratory distress, repeated vomiting, facial swelling, pain in the chest, back, and abdomen, shock, and failure in body organs such as liver, spleen and kidneys. The virus in this group of people may also lead to complications such as hearing loss, tremors, encephalitis or even death within 2 weeks after the onset of symptoms due to multiple organ failure (CDC, 2014; WHO, 2017; Yun & Walker, 2012). The number of Lassa virus infections per year in West Africa is estimated at 100,000 to 300,000, with approximately 5000 deaths. In some places in Liberia and Sierra Leone, the virus led to 10%–16% of people admitted to hospitals every year (ACDC, 2018; Gonzalez, 2020; Newman, 2018; NICD, 2020; Richmond & Baglole, 2003). In 26 out of 36 Nigerian states, a case fatality ratio of 14.8% was recorded between January 1 to February 9, 2020 (WHO, 2020).

Several studies have laid a basis to understand the dynamics of Lassa fever. Some of the studies on Lassa Fever (Ojo et al., 2021; Onah et al., 2020; Onuorah et al., 2016) only considered the basic transmission pathways namely, the human-to-human and the rodent-to-human. Because a great percentage of people show little or no symptoms of Lassa fever, Peter, et al. (Peter et al., 2020) described Lassa fever transmission dynamics using a deterministic model integrating the exposed human and rat compartment instead of the usual SIR compartmental structure. Some other studies have tried to establish the time-dependent nature of the transmission dynamics of Lassa fever. For example, Ibrahim and Dénes (Ibrahim & Dénes, 2021) used a compartmental model with time-dependent parameters where the infectious class was partitioned into symptomatically infected, mildly infected and treated individuals alongside with the carrying capacity of the rodent because of the periodic change of weather. Factors like quarantine, hospitalization of infected individuals were also used in (Ibrahim & Dénes, 2021; Musa et al., 2020) to comprehend the transmission variability of Lassa fever. The association between the reproduction number and local rainfall was used to investigate the epidemiological features of Lassa fever on a large scale (Zhao et al., 2020). Abdulhamid et al. (Abdulhamid et al., 2022) incorporated the effect of quarantine and the environment to show that in poor resource countries, Lassa fever transmission is driven by environmental contribution. Differential infectivity has also been deployed as a technique to analyze the complex nature of Lassa fever dynamics (Musa et al., 2022). In order to understand the epidemiology of the disease, it is important to look at a number of possible transmission pathways through which the virus can be contracted. In this work, we focus on the effects of multiple transmission pathways of Lassa Fever towards the progression of the infection in the human and rodent population. The use of multiple transmission routes gives us a better understanding of the epidemiological structure of Lassa fever. Our study extends the work of Peter et al. (Peter et al., 2020) and Ibrahim and Dénes (Ibrahim & Dénes, 2021) by:

  • Introducing the environment to human transmission pathway. We define the environment as the surfaces, walls and any other equipment where the virus is deposited.

  • Introducing the aerosol to human route of transmission. By aerosol, we refer to air particles where the virus is concentrated through human and wind activities.

These two pathways are not usually considered as major drivers of infection on a large scale. In endemic areas like Nigeria, a major route of infection is the contact with infected rodents through harvesting, however, recent reports (Abdulhamid et al., 2022) have also shown that the environmental pathway contribute to the burden of Lassa fever and should not be neglected. Thus, our study captures (i) human to human transmission (ii) rodent to human transmission (iii) rodent to rodent transmission (iv) environment to human transmission (v) aerosol to human transmission (vi) environment to rodent transmission. The aforementioned studies form the basic fabric for our work and the understanding gained from them will help us build and analyze a more comprehensive study with more transmission pathways. The remaining part of this work will be arranged thus: Section 2 will be the formulation of the basic model with basic analysis; In Section 3, we will perform our numerical simulations, and discussion and recommendations will be presented in Section 4.

2. Model formulation

The total human population, given as NH(t), is subdivided into five classes which consists of humans susceptible to the virus, SH(t), humans that have Lassa virus but are not infectious, EH(t), infectious humans that are asymptomatic, IHA(t), infectious humans that are symptomatic, IHS(t), and humans who have recovered from Lassa fever, RH(t) so that

NH(t)=SH(t)+EH(t)+IHA(t)+IHS(t)+RH(t). (1)

The total rodent population, given as NR(t), is subdivided into three classes consisting of rodents susceptible to the virus, SR(t), rodents that have Lassa virus but are not infectious, ER(t), and infected rodents that can transmit the virus, IR(t) with

NR(t)=SR(t)+ER(t)+IR(t). (2)

We consider the following direct transmission pathways: the human-to-human contact, the rodent-to-human contact, the rodent-to-rodent contact and the indirect transmission pathway such as the environment-to-human contact and the aerosol-to-human contact and the environment-to-rodent contact. To incorporate the indirect transmission pathways, we use VS to describe the concentration of Lassa fever virus on the environmental surfaces and VA, the concentration of Lassa virus in the air. The maximum carrying capacity of virus on environmental surfaces and in the air is given by KV, where VS, VA ≤ KV.

We assume that π1 is the constant recruitment rate of susceptible humans. The susceptible humans move to the exposed class, EH, through a force of infection

λH=βHIRNR+η1IHSNH+η2IHANH+η3VSKV+η4VAKV. (3)

Here, βH is the effective contact rate between susceptible humans and infected rodents, susceptible humans and infectious humans, susceptible humans, the virus in the environment and the virus in the air, η1 is the modification parameter which indicates that contact with IHS is less infectious than with IR. Similarly, η2, η3, η4 are also modification parameters which account for level of infectiousness of contact with IHA, VS and VA respectively. Evidence from (Bausch et al., 2010; Davies et al., 2019; Lehmann et al., 2017; Lo Iacono et al., 2015) ensures that the following inequality holds:

η4<η3<η1<η2<1.

The exposed humans progress to the infectious compartment at the rate ψ1, where the proportion of exposed individuals that become asymptomatic is νψ1 and the proportion of exposed persons that become symptomatic is (1 − ν)ψ1. Humans die naturally in all classes at the rate μ1. Infectious symptomatic humans can die due to the disease at the rate δ but there are no cases of death due to infection for the infectious asymptomatic individuals. Infectious asymptomatic and infectious symptomatic humans recover at the rates ζ1 and ζ2, respectively.

The susceptible rodents are recruited at a constant rate π2 and move to the exposed class ER through a force of infection

λR=βRIRNR+ξ1VSKV, (4)

where βR is the effective contact rate between susceptible rodents and infected rodents and between susceptible rodents and contaminated environment surfaces. ξ1 is the modification parameter which shows that contact with VS is less infectious than with IR. The exposed rodents move to the infectious class at the rate ψ2 and all rodents die naturally at a rate of μ2. Rodents can also die at a rate ρ due to consumption by humans as food. Rodents do not die due to disease since infected rodents can continue to shed the virus throughout their lifetime. The Lassa fever virus is deposited into the environment at rates of φ1, φ2 and φ3 by infectious asymptomatic humans, infectious symptomatic humans, and infected rodents respectively through activities such as urination, excretion of faeces, bleeding and fluid secretions. We further assume that the virus concentration on the environmental surfaces and in the air decays at the rate θ2 while a proportion of the virus concentration moves into the air at the rate θ3 through wind and human activities.

The Lassa fever model in Fig. 1 is expressed as a system of first order nonlinear ordinary differential equations as follows:

dSHdt=π1λHSHμ1SH,dEHdt=λHSH(ψ1+μ1)EH,dIHAdt=νψ1EH(ζ1+μ1)IHA,dIHSdt=(1ν)ψ1EH(δ+ζ2+μ1)IHS,dRHdt=ζ1IHA+ζ2IHSμ1RH,dSRdt=π2λRSR(ρ+μ2)SR,dERdt=λRSR(ψ2+ρ+μ2)ER,dIRdt=ψ2ER(ρ+μ2)IR,dVSdt=φ1IHA+φ2IHS+φ3IR(θ2+θ3)VS,dVAdt=θ3VSθ2VA, (5)

Fig. 1.

Fig. 1

The Lassa fever schematic diagram for human, virus and rodent population.

which is subject to the following initial conditions:

SH(0)=SH0>0,EH(0)=EH00,IHA(0)=IHA00,IHS(0)=IHS00,RH(0)=RH00,SR(0)=SR0>0,ER(0)=ER00,IR(0)=IR00,VS(0)=VS00,VA(0)=VA00,t0. (6)

The variables and parameter descriptions and units are presented in Table 1.

Table 1.

Description of parameters and variables for model (5).

Variables Description Unit
SH Susceptible human population people
EH Exposed human population people
IHA Infectious asymptomatic human population people
IHS Infectious symptomatic human population people
RH Recovered human population people
SR Susceptible rodent population rodents
ER Exposed rodent population rodents
IR Infected rodent population rodents
VS Concentration of Lassa virus in the environmental surfaces virus
VA
Concentration of Lassa virus in the air
virus
Parameters
Description
Unit
βH Contact rate between SH and IR, IHA, IHS, VS, VA day−1
η1 Modification parameter nil
η2 Modification parameter nil
η3 Modification parameter nil
η4 Modification parameter nil
βR Contact rate between SR and IR, VS day−1
ξ1 Modification parameter nil
ψ1 Rate of progression of humans from EH to IHA and IHS day−1
ψ2 Rate of progression of rodents from ER to IR day−1
θ2 Rate of decay of virus in VS day−1
θ3 Rate of progression of virus from VS to VA day−1
φ1 Rate at which virus is shed in VS by IHA virus/people × day
φ2 Rate at which virus is shed in VS by IHS virus/people × day
φ3 Rate at which virus is shed in VS by IR virus/rodents × day
μ1 Natural death rate of humans day−1
μ2 Natural death rate of rodents day−1
ρ Death rate of rodents due to consumption by humans day−1
ζ1 Recovery rate of IHA day−1
ζ2 Recovery rate of IHS day−1
π1 Recruitment rate of humans people/day
π2 Recruitment rate of rodents rodents/day
KV Maximum carrying capacity of virus virus
δ Disease-induced death rate of humans day−1
ν Proportion of humans progressing to IHA nil

2.1. Model analysis

Here, we show that our model is mathematically and biologically meaningful. We shall also compute the basic reproduction number and carry out the stability analysis of the steady states.

2.1.1. Feasible region

We assume that all parameters are non-negative for time t and prove that in the proposed region, Ω, the solutions remain non-negative and bounded. We will analyze the Lassa fever transmission model in the region given as:

Ω=(SH,EH,IHA,IHS,RH,SR,ER,IR,VS,VA)R+10:NHπ1μ1,NRπ2ρ+μ2,VSMS,VAMA,

where

MS=(φ1+φ2)π1μ1(θ2+θ3)+φ3π2μ2(θ2+θ3),MA=θ3π1(φ1+φ2)μ1θ2(θ2+θ3)+θ3φ3π2μ2θ2(θ2+θ3).

To show that the region Ω is positively invariant, we consider the first equation of (5)

dSHdt=π1(λH+μ1)SH,

which is solved to obtain

SH(t)=SH0e0t(μ1+λH(s))ds+π1μ1e0t(μ1+λH(s))ds×0te0s(μ1+λH(r))drds>0.

Also, for the solution component of EH(t), we suppose that there exist a first time t1 such that EH(t1)=0,EH(t1)<0 and the rest of the variables are non-negative for 0 < t1 < t. The second equation of system (5) gives

dEHdt|t=t1=λH(t1)SH(t1)>0,

which is a contradiction, so EH(t) ≥ 0, ∀ t ≥ 0.

Using a similar approach, it is easy to show that IHA, IHS, RH, SR, ER, IR, VS, VA are non-negative. Hence, all solutions of (5) are non-negative in Ω.

Now, we show that all solutions with non-negative initial conditions are bounded in the set Ω. It is easy to see that

dNHdtπ1μ1NH,dNRdt=π2(ρ+μ2)NR. (6)

Solving the differential inequality and equation in (6), we use the standard comparison theorem (Lakshmikantham et al., 1989) and the integrating factor to show that as t, we have that 0NH(t)π1μ1 and 0NR(t)=π2ρ+μ2. Similarly the differential inequalities

dVSdt(φ1+φ2)π1μ1+φ3π2μ2(θ2+θ3)VS,dVAdtθ3π1(φ1+φ2)μ1θ2+θ3φ3π2μ2θ2θ2VA,

yield VS(φ1+φ2)π1μ1(θ2+θ3)+φ3π2μ2(θ2+θ3)=MS,VAθ3π1(φ1+φ2)μ1θ2(θ2+θ3)+θ3φ3π2μ2θ2(θ2+θ3)=MA.

Thus, all possible solutions of (5) enter the region Ω and stay inside it. Hence, the region Ω is positively invariant and attracting and therefore a feasible region.

2.1.2. Reproduction number and equilibria stability analysis

We explore the existence of the equilibrium points of model (5). To obtain the disease free equilibrium (DFE), we equate the right hand side of model (5) to zero and solve when EH = IHA = IHS = ER = IR = VS = VA = 0 to get:

E0=π1μ1,0,0,0,0,π2ρ+μ2,0,0,0,0.

The basic reproduction number R0 of model (5) is the dominant eigenvalue of the matrix FV−1 using the next generation matrix approach (Van den Driessche & Watmough, 2002). Here,

F=λHSH00λRSR000,V=(ψ1+μ1)EHνψ1EH+(ζ1+μ1)IHA(1ν)ψ1EH+(δ+ζ2+μ1)IHS(ψ2+ρ+μ2)ERψ2ER+(ρ+μ2)IRφ1IHAφ2IHSφ3IR+(θ2+θ3)VSθ3VS+θ2VA.

Computing the Jacobian of F and V evaluated at E0 we get

F=0βHη2βHη10βHμ2π1μ1π2βHη3π1μ1KVβHη4π1μ1KV000000000000000000βRβRξ1π2μ2KV0000000000000000000000,
V=ψ1+μ1000000νψ1ζ1+μ100000(1ν)ψ10δ+ζ2+μ10000000ψ2+ρ+μ2000000ψ2ρ+μ2000φ1φ20φ3(θ2+θ3)000000θ3θ2.

The inverse of V is given as

V1=1μ1+ψ1000000νψ1ζ1+μ1μ1+ψ11ζ1+μ100000(1+ν)ψ1δ+ζ2+μ1μ1+ψ101δ+ζ2+μ100000001μ2+ρ+ψ2000000ψ2ρ+ψ2μ2+ρ+ψ21ρ+ψ200v61φ1(θ2+θ3)ζ1+μ1v63v64φ3(θ2+θ3)ρ+ψ21(θ2+θ3)0v71θ3φ1θ2(θ2+θ3)ζ1+μ1v73v74θ3φ3θ2(θ2+θ3)ρ+ψ2θ3θ2(θ2+θ3)1θ2

where

v61=δ+ζ2+μ1νψ1φ1+(1+ν)ζ1+μ1φ2ψ1(θ2+θ3)ζ1+μ1δ+ζ2+μ1μ1+ψ1,v63=φ2(θ2+θ3)δ+ζ2+μ1,v64=φ3ψ2(θ2+θ3)ρ+ψ2μ2+ρ+ψ2,v71=θ3δ+ζ2+μ1νψ1φ1+(1+ν)ζ1+μ1φ2ψ1θ2(θ2+θ3)ζ1+μ1δ+ζ2+μ1μ1+ψ1,v73=θ3φ2θ2(θ2+θ3)δ+ζ2+μ1,v74=θ3φ3ψ2θ2(θ2+θ3)ρ+ψ2μ2+ρ+ψ2. (7a)

The next generation matrix evaluated at DFE is

FV1=b11b12b13b14b15b16b1700000000000000b41b42b43b44b45b460000000000000000000000,

where

b11=βHKVθ2(θ2+θ3)μ1(η2(δ+ζ2+μ1)νψ1+(1ν)η1(ζ1+μ1)ψ1)KVθ2(θ2+θ3)μ1(ζ1+μ1)(δ+ζ2+μ1)(μ1+ψ1)+βH(π1(η3θ2+η4θ3)((δ+ζ2+μ1)νψ1φ1+(1ν)(ζ1+μ1)φ2ψ1))KVθ2(θ2+θ3)μ1(ζ1+μ1)(δ+ζ2+μ1)(μ1+ψ1),b12=βHη2ζ1+μ1+π1βHη3φ1KV(θ2+θ3)μ1ζ1+μ1+π1βHη4θ3φ1KVθ2(θ2+θ3)μ1ζ1+μ1,b13=βHη1δ+ζ2+μ1+π1βHη3φ2KV(θ2+θ3)μ1δ+ζ2+μ1+π1βHη4θ3φ2KVθ2(θ2+θ3)μ1δ+ζ2+μ1,b14=π1βHKVθ2(θ2+θ3)μ2+π2η3θ2+η4θ3φ3ψ2KVπ2θ2(θ2+θ3)μ1ρ+ψ2μ2+ρ+ψ2,b15=π1βHμ2π2μ1ρ+ψ2+π1βHη3φ3KV(θ2+θ3)μ1ρ+ψ2+π1βHη4θ3φ3KVθ2(θ2+θ3)μ1ρ+ψ2,b16=π1βHη3KV(θ2+θ3)μ1+π1βHη4θ3KVθ2(θ2+θ3)μ1,b17=π1βHη4KVθ2μ1,b41=π2βRξ1δ+ζ2+μ1νψ1φ1+(1ν)ζ1+μ1φ2ψ1KV(θ2+θ3)ζ1+μ1δ+ζ2+μ1μ2μ1+ψ1,b42=π2βRξ1φ1KV(θ2+θ3)ζ1+μ1μ2,b43=π2βRξ1φ2KV(θ2+θ3)δ+ζ2+μ1μ2,b44=βRKV(θ2+θ3)μ2+π2ξ1φ3ψ2KV(θ2+θ3)μ2ρ+ψ2μ2+ρ+ψ2,b45=βRρ+ψ2+π2βRξ1φ3KV(θ2+θ3)μ2ρ+ψ2,b46=π2βRξ1KV(θ2+θ3)μ2. (7b)

The basic reproduction number is given by

R0=b11+b442+(b11b44)2+4b14b412. (7c)
Remark 2.1.1
  • (i)

    The terms contained in R0 represent the direct and indirect transmission pathways. They are described thus: b11 is the local reproduction number of infectious asymptomatic humans, infectious symptomatic humans, contaminated environmental surfaces and contaminated air particles in the progression of Lassa Fever virus in the human population only; b44 is the local reproduction number of infected rodents and contaminated environmental surfaces in the progression of Lassa Fever virus in the rodent population only; b14 is the local reproduction number of contaminated environmental surfaces and contaminated air particles in the progression of Lassa Fever virus in the human population only; and b41 is the local reproduction number of contaminated environmental surfaces in the progression of Lassa Fever virus in the rodent population only.

  • (ii)

    It is easy to see that

(b11b44)2+4b14b41=(b11+b44)2+4(b14b41b11b44).

Thus, b14b41 > b11b44 implies that R0 > 0. This condition ensures that infection will be sustained across from rodents to humans and from humans to rodents via all the transmission pathways.

  • (iii)

    The local stability of the disease free equilibrium point when R0 < 1 is ensured by the hypothesis used in the computation of R0 (Van den Driessche & Watmough, 2002).

Theorem 2.1.1

The disease free equilibrium point is globally asymptotically stable ifR0 < 1.

Proof. It suffices to show that our model (5) satisfy conditions H1 and H2 of the global stability theorem by (Castillo-Chavez et al., 2002) when R0 < 1.

Model (5) can be rewritten in the form

dXdt=F(X,Y),dYdt=G(X,Y),G(X,0)=0.

Here, X=(SH,SR)T, Y=(EH,IHA,IHS,ER,IR,VS,VA)T, XR+2 represents the number of susceptible humans and rodents and YR+7 represents the number of exposed humans, asymptomatic infectious humans, symptomatic infectious humans, exposed rodents, infected rodents, contaminated environment and contaminated air.

Our DFE is now written as E0 = (X, 0) where X0=(π1μ1,π2ρ+μ2) and we show that the following conditions are satisfied:

  • H1: For dXdτ=F(X0,0),X0 is globally asymptotically stable.

  • H2: G(X,Y)=AYG^(X,Y), G^(X,Y)0 for (X, Y) ∈ Ω where A = DY(G(X0, 0)) is an M-matrix and Ω is the region where the model makes biological sense.

For the first condition H1, we have

dSHdt=π1μ1SH,dSRdt=π2(ρ+μ2)SR, (8)

which can be solved to get

SH(t)=π1μ1+π1μ1SH0eμ1t,SR(t)=π2ρ+μ2+π2ρ+μ2SR0e(ρ+μ2)t.

We take limits as t to get,

limtSH(t)=π1μ1,limtSR(t)=π2ρ+μ2.

Hence, the solutions of equation (8) converge to X0 regardless of the initial conditions. Therefore, X0 is a globally asymptotically equilibrium point of (8).

For condition H2, we consider F(X,0)=(π1μ1SH,π2(ρ+μ2)SR),G(X,Y)=AYG^(X,Y)

where

G(X,Y)=λHSH(ψ1+μ1)EHνψ1EH(ζ1+μ1)IHA(1ν)ψ1EH(δ+ζ2+μ1)IHSλRSR(ψ2+ρ+μ2)ERψ2ER(ρ+μ2)IRφ1IHA+φ2IHS+φ3IR(θ2+θ3)VSθ3VSθ2VA,

and

A=(ψ1+μ1)βHη2βHη10βHμ2π1μ1π2βHη3π1μ1KVβHη4π1μ1KVνψ1(ζ1+μ1)00000(1ν)ψ10(δ+ζ2+μ1)0000000(ψ2+ρ+μ2)βRβRξ1π2μ2KV0000ψ2(ρ+μ2)000φ1φ20φ3(θ2+θ3)000000θ3θ2,

which is an M-matrix and

G^(X,Y)=βHη2(SH0SH)+βHη1(SH0SH)+βHμ2π2(SH0SH)+βHη3KV(SH0SH)+βHη4KV(SH0SH)00βR(SR0SR)+βRξ1KV(SR0SR)000.

Clearly, G^(X,Y)0 since 0SHSH0 and 0SRSR0. □

The global stability of E0 thus follows and the Lassa fever virus can be eliminated from the human and rodent population over a period of time provided R0 < 1.

The endemic equilibrium point of the model (5) is given by

E=(SH,EH,IHA,IHS,RH,SR,ER,IR,VS,VA),

where

SH=π1λH+μ1,EH=π1λH(ψ1+μ1)(λH+μ1),IHA=νψ1π1λH(ζ1+μ1)(ψ1+μ1)(λH+μ1),IHS=(1ν)ψ1π1λH(δ+ζ2+μ1)(ψ1+μ1)(λH+μ1),RH=ζ1νψ1π1λHμ1(ζ1+μ1)(ψ1+μ1)(λH+μ1)+ζ2(1ν)ψ1π1λHμ1(δ+ζ2+μ1)(ψ1+μ1)(λH+μ1),SR=π2λR+ρ+μ2,ER=π2λR(ψ2+ρ+μ2)(λR+ρ+μ2),IR=ψ2π2λR(ρ+μ2)(ψ2+ρ+μ2)(λR+ρ+μ2),VS=φ1νψ1π1λH(θ2+θ3)(ζ1+μ1)(ψ1+μ1)(λH+μ1)+φ2(1ν)ψ1π1λH(θ2+θ3)(δ+ζ2+μ1)(ψ1+μ1)(λH+μ1)+φ3ψ2π2λR(θ2+θ3)(ρ+μ2)(ψ2+ρ+μ2)(λR+ρ+μ2),VA=θ3φ1νψ1π1λHθ2(θ2+θ3)(ζ1+μ1)(ψ1+μ1)(λH+μ1)+θ3φ2(1ν)ψ1π1λHθ2(θ2+θ3)(δ+ζ2+μ1)(ψ1+μ1)(λH+μ1)+θ3φ3ψ2π2λRθ2(θ2+θ3)(ρ+μ2)(ψ2+ρ+μ2)(λR+ρ+μ2), (9)

and

λH=βHIRNR+η1IHSNH+η2IHANH+η3VSKV+η4VAKV, (9)
λR=βRIRNR+ξ1VSKV. (10)

Equations (9), (9), (10) can be written explicitly as

λH=μ1b11λH(λH+μ1)+μ1π2b14λRπ1(λR+ρ+μ2), (11)
λR=μ2π1b41λHπ2(λH+μ1)+μ2b44λR(λR+ρ+μ2). (12)

We see that the state variables are expressed in terms of λH and λR. From here, we proceed by using the approach in (Moghadas et al., 2003; Velasco-Hernandez & Hsieh, 1994). Hence, we can obtain positive equilibrium points of the model by finding the fixed points of equations (11), (12) as

c(λH,λR)=c1(λH,λR)c2(λH,λR),

where

c1(λH,λR)c2(λH,λR)

corresponds to the right hand sides of equations (11), (12).

Theorem 2.1.2

There exists a unique fixed point(λH,λR),λH>0,λR>0which satisfies

c(λH,λR)=c1(λH,λR)c2(λH,λR)

and corresponds to the endemic equilibrium point E∗ (Moghadas et al., 2003; Velasco-Hernandez & Hsieh, 1994).

Proof. From the first equation, we fix λR > 0 and look at the real-valued function depending on λH:

c1λR(λH)=μ1b11λH(λH+μ1)+μ1π2b14λRπ1(λR+ρ+μ2).

We have that

limλH0c1λR(λH)=μ1π2b14λRπ1(λR+ρ+μ2)<,

and

limλHc1λR(λH)=μ1b11+μ1π2b14λRπ1(λR+ρ+μ2)<.

It follows that 0<c1λR(λH)< which implies that c1λR(λH) is bounded for every fixed λR > 0.

Next,

c1λR(λH)λH=μ12b11(λH+μ1)2,

and

2c1λR(λH)2λH=2μ12b11(λH+μ1)3.

c1λR(λH) is an increasing concave down function since c1λR(λH)λH>0 and 2c1λR(λH)2λH<0. Hence, there is no change in concavity of c1 in the bounded domain. It follows that there exists a unique λH>0 which satisfies c1λR(λH)=λH.

For this λH>0, we look at the real-valued function depending on λR:

c2λH(λR)=μ2π1b41λHπ2(λH+μ1)+μ2b44λR(λR+ρ+μ2).

Then,

limλR0c2λH(λR)=μ2π1b41λHπ2(λH+μ1)<,

and

limλRc2λH(λR)=μ2b44+μ2π1b41λHπ2(λH+μ1)<.

It follows that 0<c2λH(λR)< which implies that c2λH(λR) is bounded for every fixed λH>0.

Next,

c2λH(λR)λR=μ2b44(ρ+μ2)(λR+ρ+μ2)2,

and

2c2λH(λR)2λR=2μ2b44(ρ+μ2)(λR+ρ+μ2)3.

c2λH(λR) is an increasing concave down function since c2λH(λR)λR>0 and 2c2λH(λR)2λR<0. Hence, there is no change in the concavity of c2 in the positive domain. It follows that there exists a unique λR>0 which satisfies c2λH(λR)=λR.

Therefore, there is a fixed point (λH,λR) which corresponds to the endemic equilibrium point E∗. □

We now investigate the stability of the equilibrium points using the stability of the fixed point system (λH,λR) corresponding to E∗. The Jacobian of the system is given by:

J(λH,λR)=c1λHc1λRc2λHc2λR, (13)

where

c1λH=μ12b11(λH+μ1)2,c1λR=μ1π2b14(ρ+μ2)2π1μ2(λR+ρ+μ2)2,c2λH=μ1μ2π1b41π2(λH+μ1)2,c2λR=b44(ρ+μ2)2(λR+ρ+μ2)2.

We note that J(λH,λR) evaluated at the fixed point, (λH,λR)=(0,0), is given by

J(0,0)=b11μ1π2b14π1μ2μ2π1b41π2μ1b44,

and for stability, we require that |λi| < 1, where λi are the eigenvalues of J(0, 0), which corresponds to

R0=b11+b442+(b11b44)2+4b14b412<1. (14)

Hence, the stability of (λH,λR)=(0,0) is achieved when R0 < 1. The point is unstable provided R0 > 1. Thus, the stability of (λH,λR)=(0,0) corresponds to the stability of E0 when R0 < 1. Now, for (λH,λR)(0,0), we have

J(λH,λR)=d11d12d21d22,

and for stability, we require that |λi| < 1, that is,

|d11+d222+(d11d22)2+4d12d212|<1,

where

d11=μ12b11(λH+μ1)2,d12=μ1π2b14(ρ+μ2)2π1μ2(λR+ρ+μ2)2,d21=μ1μ2π1b41π2(λH+μ1)2,d22=b44(ρ+μ2)2(λR+ρ+μ2)2.

The stability of the fixed point system is governed by the fact that the absolute value of the eigenvalues of the fixed point system is less than unity (Moghadas et al., 2003; Velasco-Hernandez & Hsieh, 1994). Hence, |λi| < 1 corresponds to

1+d11d22d11+d22+d12d21>1. (15)

Defining the left hand side of (15) as R(λH,λR), the fixed point (λH,λR)(0,0) is stable when R(λH,λR)>1.

2.1.3. Global stability of endemic equilibrium and bifurcation analysis

We first show that E∗ is globally asymptotically stable using the following theorem:

Theorem 2.1.3

The endemic equilibrium pointEof model (5) is globally asymptotically stable when μ2π1b41π2(c+μ1)+μ2b44(c+ρ+μ2)>1.

Proof. We use the geometric approach in (Li & Muldowney, 1996). Let us consider the fixed point system (11) and (12). We convert it to a root finding problem to get

f1^=μ1b11λH(λH+μ1)+μ1π2b14λRπ1(λR+ρ+μ2)λH,f2^=μ2π1b41λHπ2(λH+μ1)+μ2b44λR(λR+ρ+μ2)λR. (16)

The Jacobian matrix corresponding to this system is

J=f111f12f21f221,

where

f11=μ12b11(λH+μ1)2,f12=μ1π2b14(ρ+μ2)π1(λR+ρ+μ2)2,f21=μ1μ2π1b41π2(λH+μ1)2,f22=μ2b44(ρ+μ2)(λR+ρ+μ2)2.

The second additive compound matrix (Muldowney, 1990) of J is

J[2]=μ12b11(λH+μ1)2+μ2b44(ρ+μ2)(λR+ρ+μ2)22[C].

We assume the function

Q=Q(λH,λR)=λHλR00λHλR,

we have

Q1=λRλH00λRλH,Qf=λRλH˙λHλR˙λH200λRλH˙λHλR˙λH2,QfQ1=λH˙λHλR˙λR00λH˙λHλR˙λR,QJ[2]Q1=C00C.

We define

B=QfQ1+QJ[2]Q1=B11B12B21B22,

where B11=B22=λH˙λHλR˙λR+C,B12=B21=0.

Using

λR˙λR=μ2π1b41λHπ2λR(λH+μ1)+μ2b44(λR+ρ+μ2)1,

Then

B11=B22=λH˙λHμ2π1b41λHπ2λR(λH+μ1)μ2b44(λR+ρ+μ2)+1.

We follow the approach in (Li & Muldowney, 1996) to get

ν(B)sup{g1,g2}sup{ν1(B11)+|B12|,ν1(B22)+|B21|},

where ν1 denotes the Lozinskii measure with respect to the L1 norm and |B12|, |B21| are matrix norms with respect to the L1 vector norm. So,

ν(B)λH˙λHμ2π1b41λHπ2λR(λH+μ1)μ2b44(λR+ρ+μ2)+1.

Using Lemma 1 in (Srivastava et al., 2022) and the uniform persistence result in (Freedman et al., 1994), this gives us

ν(B)λH˙λHμ2π1b41π2(c+μ1)+μ2b44(c+ρ+μ2)1.

We choose Δ=μ2π1b41π2(c+μ1)+μ2b44(c+ρ+μ2)1>0, so

ν(B)λH˙λHΔ.

Integrating both sides, we get

0tν(B)ds0tλH˙λHdt0tΔdt,

and it follows that

1t0tν(B)ds1tlogλH(t)λH(0)Δ,

or

lim suptsup1t0tν(B)dsΔ0, (17)

as λH(t) is bounded and Δ >0

Hence, q2ˆ=lim suptsup1t0tν(B)ds<0, if Δ > 0 or μ2π1b41π2(c+μ1)+μ2b44(c+ρ+μ2)>1.

Thus, system (16) is globally asymptotically stable for μ2π1b41π2(c+μ1)+μ2b44(c+ρ+μ2)>1, that is (λH,λR)(λH,λR) as t. □

Next, we investigate conditions on the parameter values in model (5) using Center Manifold Theory (Castillo-Chavez & Song, 2004).

Theorem 2.1.4
  • (i)

    IfβHμ2π2w1v2w1<βHπ1μ22π22μ1w6v2w8andb > 0, then the system (5) will undergo a forward bifurcation at R0 = 1.

  • (ii)

    IfBwv<βHμ2π2w1v2w1βHπ1μ22π22μ1w6v2w8, andb > 0, then the system (5) will undergo a backward bifurcation at R0 = 1.

(Castillo-Chavez & Song, 2004).

Proof. See Appendix A. □

3. Numerical simulations

3.1. Parameter estimation

It is crucial to estimate the model parameter values in order for us to perform numerical analysis. We consider the ecological niche where Lassa fever is endemic. We focus on three (3) states in Nigeria (Ondo, Edo and Ebonyi) where this virus has ravaged communities in the past few years based on Nigeria Centre for Disease Control (NCDC) reports (NCDC, 2021).

In the chosen region, we consider a few local sites in the three states of about 10000 persons, π1μ1=10000. The human natural death rate is μ1=155.12×365 day−1 using the average human lifespan in Nigeria as 55.12 (Trends, 2021). The daily recruitment rate of humans is estimated as π1 = 10000 × μ1 = 0.497 day−1. The value, ν = 0.8 since 80% of individuals are asymptomatic. The sample study of Lassa fever cases in Nigeria shows a case fatality ratio of 18.9% in the year 2021 (NCDC, 2021), we assume δ = 0.189 year−1 which translates to δ = 0.0005 day−1. Research conducted in these communities had reported a yearly rodent consumption rate of 29.9% in Edo State, 11% in Ebonyi State and 20.2% in Ondo State (Ossai et al., 2020; WHO, 2021). So, we use an average consumption rate of 20.4% per year giving us ρ = 0.0006 day−1. The biological half-life of Lassa virus ranges from 10.1 to 54.6 min (Stephenson et al., 1984); so using 10.1 min implies that θ3=2×10.160×24 day−1.

We consider a hypothetical average population of Mastomys rat to be π2μ2=1000, since there is no known quantified estimate of the rodents population. The average lifespan of a rodent is 1 year (Control, 2018), so we obtain μ2=11×365 day−1. We estimate the rodent recruitment rate to be π2 = 1000 × μ2 = 2.74 day−1. Some of the parameters cannot be found or estimated from literature, so we used model calibration to get ideal representation curves for all state variables to get approximate values. Thus ψ1 = 0.0094 day−1, ψ2 = 0.048 day−1, βH = 0.00017 day−1, βR = 0.004 day−1, ξ = 0.167, φ1=115, φ2=128, φ3=3.760×24 and the values of η1, η2, η3, η4, to lie in the interval (0, 1). For our simulation, we use the following initial conditions: SH(0) = 10000, EH(0) = 0, IHA(0) = 324, IHS(0) = 81, RH(0) = 10, SR(0) = 1000, ER(0) = 0, IR(0) = 100, VS(0) = 1000, VA(0) = 100. Table 2 contains the parameter values used in the simulations.

Table 2.

Parameter values and references.

Parameters Value Reference
π1 0.497 Calculated
π2 2.74 Calculated
μ1 0.0000497 Trends (2021)
μ2 0.00274 Control (2018)
ψ1 0.0094 Assumed
ψ2 0.048 Assumed
βH 0.00017 Assumed
βR 0.004 Assumed
ρ 0.0006 (Ossai et al., 2020; WHO, 2021)
ν 0.8 (CDC, 2014; WHO, 2017; Yun & Walker, 2012)
ζ1 0.0000476 Estimated
ζ2 0.0000323 Estimated
δ 0.0005 NCDC (2021)
θ2 0.01868 Estimated
θ3 0.00701 Stephenson et al. (1984)
φ1 0.0667 Assumed
φ2 0.0357 Assumed
φ3 0.02569 Assumed
ξ1 0.167 Assumed
η1 0.94 Assumed
η2 0.95 Assumed
η3 0.9 Assumed
η4 0.85 Assumed

3.2. Sensitivity analysis

Sensitivity analysis is a procedure used to determine the strength of model predictions to parameter values. It is crucial because there are usually flaws in assumed parameter values and generally in data collection. Sensitivity analysis shows the parameters that deserve the best numerical attention, reveals insensitive parameters that do not require much effort to estimate and shows which parameters should be targeted for intervention (Mikucki, 2012). Local sensitivity analysis is based on calculating the effect on the model output of small perturbations around a nominal parameter value. This perturbation is done on one parameter at a time using the first-order partial derivative of the model output with respect to the perturbed parameter. Here, we will investigate parameters that have a high impact on R0, and should be targeted by intervention strategies. The global sensitivity analysis, on the other hand, seeks to explore the input parameters space across its range of variation and then quantify the input parameter importance based on a characterization of the resulting output response surface. It is a sampling-based method that investigates uncertainties for parameter values in the entire parameter range (Blower & Dowlatabadi, 1994; Marino et al., 2008; Saltelli et al., 2004, 2008; Turányi, 1990). We will perform both the local and global sensitivity analysis.

3.2.1. Local sensitivity analysis of R0

We calculate the local sensitivity indices of the parameters with respect to R0 using the normalized forward index. These indices reveal the importance of each parameter to disease transmission and should be taken into consideration while defining our control strategies. According to (Chitnis et al., 2008), the normalized forward sensitivity index of a variable u that depends differentiably on a parameter ρ is defined as:

ϒρu=uρ×ρu.

For example, the sensitivity index of R0 with respect to βH will be

ϒβHR0=R0βH×βHR0.

When ϒβHR0>0, we say that βH increases the value of R0 as its value increases, while if ϒβHR0<0, then βH decreases the value of R0 as its value increases. The results of the sensitivity indices is shown in Table 3.

Table 3.

Sensitivity indices of R0.

Parameters Sensitivity indices of R0 Parameters Sensitivity indices of R0
π1 0.444782 δ −0.0272335
π2 0.0000581831 θ2 −0.439338
μ1 −0.946283 θ3 −0.00550217
μ2 −0.000168322 φ1 0.43505
ψ1 0.00524857 φ2 0.00973221
ψ2 −0.00190397 φ3 0.0000581831
βH 0.997936 ξ1 0.00199971
βR 0.0020637 η1 0.0219675
ρ −0.0000495958 η2 0.531187
ν 0.839438 η3 0.32696
ζ1 −0.472691 η4 0.115881
ζ2 −0.00175928

We observe from Table 3 that parameters such as βH, ν, η2, π1, φ1, η3, η4, η1, βR, ξ1 are positively correlated with R0 thus increase in these parameters increase the reproduction number. The parameters μ1, ζ1, δ, θ2 are negatively correlated with R0 thus they decrease the value of R0 as they are increased. There are parameters such as π2, μ2, ρ, φ3 that are insensitive with respect to the reproduction number of Lassa fever in the population. These parameters do not require too much effort to estimate and will not cause much changes to R0 when they are increased or decreased. All parameters associated with infection pathways have positive indices and thus, all the infection pathways have a potential to collectively or otherwise increase the infection. We also observe that βH is the most sensitive parameter followed by ν, η2, π1, φ1, η3, η4, η1, βR, ξ1 respectively. Intervention strategies can be targeted at reducing the impact of parameters which increase R0 whilst increasing those that reduce it.

3.2.2. Global sensitivity analysis

The global sensitivity analysis is carried out using the Latin Hypercube Sampling and Partial Rank Correlation Coefficients (PRCCs) (Marino et al., 2008). This is a robust sensitivity measure that combines uncertainty analysis with partial correlation on rank-transformed data to assess the sensitivity of our outcome variable to parameter variation. Fig. 2, Fig. 3 shows that the parameters βH, βR, φ1, φ3, θ3, ψ1, ν are positively correlated to CH and thus increase the burden of Lassa fever infection in the human population; the parameters θ2, μ2, π1 are negatively correlated to CH and decrease the burden of Lassa virus in the human population when they are increased. There are also insensitive parameters ψ2, μ1, ψ1, ζ1, ζ2, φ2 with PRCCs very close to zero. The parameters associated with infection pathways though weakly correlated, remain positively correlated in the different populations. In the rodent population, the parameters βH, βR, ψ1, ψ2, μ1, μ2, θ3 are positively correlated to CR and increase the infection burden in rodents, parameters π1, π2, μ2, φ2, ρ, μ2, θ3 are negatively correlated to CR while there are parameters with PRCCs close to zero such as δ, θ3, ζ1, ζ2 and so on. From the PRCCs of the virus population, we see positively correlated parameters such as βR, ψ2, π2, μ1, ξ1, negatively correlated parameters μ2, ρ, π1 and other parameters with PRCCs very close to zero. In all populations, we see that some parameters are positively or negatively correlated at certain time points but become insensitive at other time points and verse visa. Hence, the interplay and the exchange of sensitivity by different parameters on different variables alludes to the complexities brought about by the multiple transmission pathways which in turn suggest the importance of every pathway in the prognosis of Lassa fever.

Fig. 2.

Fig. 2

Partial Rank Correlation Coefficient for the full range of parameters of model (5) in the cumulative cases of human and rodent population.

Fig. 3.

Fig. 3

Partial Rank Correlation Coefficient for the full range of parameters of model (5) in the cumulative cases of virus population.

3.3. Simulation results

Fig. 4 shows the baseline graphs of system (5) without varying the system parameters. The simulations were done over a time period of 40000 days. The baseline graph is perceived to represent the ideal situation where Lassa fever persists in the system. We will illustrate the impact of the transmission pathways in the next subsection.

Fig. 4.

Fig. 4

Model simulations for all the state variables in model (5) with R0 greater than unity: R0 = 3.1301.

3.3.1. Simulation of the transmission pathways

We now investigate the impact of the various transmission routes on the progression of Lassa fever in both human and rodent population as well as the growth of virus in the environment. We shall proceed using the following strategies:

  • 1.
    Transmission pathways for the human population
    • (a)
      5 Single transmission pathways (see Fig. 5).
    • (b)
      10 combinations of two transmission pathways (see Fig. 6).
    • (c)
      10 combinations of three transmission pathways (see Fig. 7).
    • (d)
      5 combinations of four transmission pathways (see Fig. 8).
    • (e)
      1 combination of five transmission pathways (see Fig. 9).
  • 2.
    Transmission pathways for rodent population
    • (a)
      Single transmission pathways (see Fig. 9).
    • (b)
      1 combination of two transmission pathways (see Fig. 10).
Fig. 5.

Fig. 4

Graphical illustration of model (5) for single transmission routes on the cumulative cases of human, rodent and virus classes.

Fig. 6.

Fig. 6

Graphical illustration of model (5) for possible combination of two transmission routes on the cumulative cases of human, rodent and virus classes.

Fig. 7.

Fig. 7

Graphical illustration of model (5) for possible combination of three transmission routes on the cumulative cases of human, rodent and virus classes.

Fig. 8.

Fig. 8

Graphical illustration of model (5) for possible combination of four transmission routes on the cumulative cases of human, rodent and virus classes.

Fig. 9.

Fig. 9

Graphical illustration of model (5) for all possible combination of transmission routes alongside one transmission route on the cumulative cases of human, rodent and virus classes.

Fig. 10.

Fig. 10

Graphical illustration of model (5) for possible combination of the two rodent transmission routes on all the classes.

By single transmission pathway, we use each of the single contact rates in the human force of infection and test its impact on the system while the entire rodent force of infection is operational. We do the same for two transmission routes and continue till we exhaust all other transmission pathways. We also investigate using each of the single contact rates in the rodent force of infection and the two transmission routes while keeping the entire human force of infection in use. We shall test these strategies using the cumulative cases (NCDC, 2021) in the humans, rodents and virus in the environment. To capture this, we will simulate the cumulative cases using the equations:

dCHdt=ψ1EH,dCRdt=ψ2ER,dCVSdt=φ1IHA+φ2IHS+φ3IR, (19)

subject to the initial conditions CH(0)=0,CR(0)=0,CVS(0)=505, where CH is the cumulative infection cases in the human population, CR is the cumulative infection cases in the rodent population, and CVS is the cumulative infection cases in the virus population.

Fig. 5 reveals that the effective contact rate between susceptible humans and infected rodents does the most damage with regards to the progression of infection. This is followed by the contact rate between susceptible humans and infectious asymptomatic humans which is less infectious and then by the contact with contaminated environment, contaminated air, and infectious symptomatic humans. We observe that every single route of transmission plays a role in driving the Lassa fever infection even though some are less significant than the others. In the rodent population, we also see a notable difference in the level of infectiousness of the transmission routes likewise in the virus population. This shows that some pathways are more deadly than others yet every pathway makes their own contribution. We see from Fig. 6 that a combination of two transmission pathways increases disease burden more than a single pathway. We also see that some combinations are more deadly than others. Any combination with the effective contact rate between susceptible humans and infected rodents produces a surge of infections followed by any combination with the effective contact rate between susceptible humans and infectious asymptomatic humans and then other pathways. Overall, we see that as the number of transmission routes increase, the burden of infection increases also (see Fig. 7, Fig. 8). Fig. 9 shows a combination of all the transmission routes plotted alongside the dominant single transmission pathway. The region between the two graphs accounts for the contribution of other pathways in combination with the effective contact rate between susceptible humans and infected rodents. This shows that even though the effective contact rate between susceptible humans and infected rodents is dominant, other pathways should not be neglected because when they work in combination, there is an additional increase in the burden of Lassa fever over a cumulative period of time. It is also important to note that horizontal transmissions between susceptible rodents and infected rodents also play a huge role in increasing the infection as well as contact rate between susceptible rodent and contaminated environmental surfaces (see Fig. 10).

3.4. Discussion of results

We investigated the transmission dynamics of Lassa fever infection incorporating multiple transmission routes to capture their impact on the progression of the infection. Using a deterministic model that accounts for Lassa fever infection, we were able to show how incorporating several transmission pathways affects the prevalence of the disease. We used some mathematical tools to establish the local stability of the endemic equilibrium and the global stability of the disease free equilibrium. From our analysis, we got mathematical expressions that shows the conditions for which the disease will persist or be controlled in the system and illustrated sensitivity of parameters changes as system dynamics progress.

From our model simulations, we see that every transmission pathway has an impact towards the progression of Lassa fever. However, there are some routes of transmission that contribute significantly more than others. Control measures should be targeted more on the contact rates between susceptible humans and infected rodents (especially in areas where rodent consumption is high), and contact rates between susceptible humans and infectious asymptomatic humans. A great challenge arises when dealing with susceptible and asymptomatic infected humans pathway because they are not easily identified through symptoms. This calls for control methods that can detect this category of people such as mass testings in endemic areas, vaccination and so on. It is also important not to neglect the contact rates between susceptible humans and contaminated air particles especially in health centres with recorded Lassa fever cases and the contact rates between susceptible humans and contaminated environment (especially in poorly sanitized areas) because they are further drivers of infection (CDC, 2014).

Most single transmission routes are less harmful, but when they operate in combination with other transmission routes, they contribute additional damage to the system. Studies (Ibrahim & Dénes, 2021; Ojo et al., 2021; Onah et al., 2020; Peter et al., 2020) that only concentrated on the human and rodent direct transmission routes have not captured valuable information on the environmental impact towards the progression of the infection. This work gives a more comprehensive breakdown of the transmission dynamics of Lassa fever as it integrates indirect transmission routes which are sometimes neglected but play a crucial role in increasing the infection statistics. Current reports show that about four medical doctors died and 38 health workers were infected during a recent Lassa fever outbreak in Nigeria (NCDC, 2022; Punch, 2022). This increase in the death of health workers tells of the fact that serious measures should be taken to curb the spread of the virus through the indirect transmission routes like the environmental surfaces and aerosol. This will help to reduce the impact of these indirect transmission routes on the infection chain. Public health agencies in Nigeria have done a lot in mitigating Lassa fever infection through administering Ribavirin, public awareness campaigns amongst others. A lot still needs to be done in endemic areas by adequate fumigation of the environment and provision of protective gears for health workers. The results from our work show that interventions on these areas should not be undermined during health policy making. Further studies can be targeted at.

  • combination of multiple routes of transmission incorporating the effect of seasonality of infection,

  • proper sanitation, intervention strategies and holistic control measures that integrate these multiple transmission pathways which can help public health reduce disease prevalence,

  • optimizing cost of several control measures using Cost Effective Analysis so that individuals in endemic areas with issues of poverty can be properly assisted.

Access to real field data can also improve the predictive capacity of the current model. Vertical transmission of Lassa fever in rodents can also be incorporated in further studies. Alternative techniques like the scaling of the model can be used to help simplify the analysis where parameters are dimensionless and express ratios of physical effects rather than levels of individual effects(Ledder, 2017).

Declaration of competing interest

The Authors declare no conflict of interest in this work.

Handling Editor: Dr HE DAIHAI

Footnotes

Peer review under responsibility of KeAi Communications Co., Ltd.

Appendix A. Sample Appendix Section

Proof. Let xi=(x1,x2,x3,x4,x5,x6,x7,x8,x9,x10)T=(SH,EH,IHA,IHS,RH,SR,ER,IR,VS,VA)T.

Then, model (5) can be written in the form dxidt=g(x) as follows:

dx1dt=g1=π1λHx1μ1x1,dx2dt=g2=λHx1(ψ1+μ1)x2,dx3dt=g3=νψ1x2(ζ1+μ1)x3,dx4dt=g4=(1ν)ψ1x2(δ+ζ2+μ1)x4,dx5dt=g5=ζ1x3+ζ2x4μ1x5,dx6dt=g6=π2λRx6(ρ+μ2)x6,dx7dt=g7=λRx6(ψ2+ρ+μ2)x7,dx8dt=g8=ψ2x7(ρ+μ2)x8,dx9dt=g9=φ1x3+φ2x4+φ3x8(θ2+θ3)x9,dx10dt=g10=θ3x9θ2x10, (A.1)

where

λH=βHx8x6+x7+x8+βHη1x4x1+x2+x3+x4+x5+βHη2x3x1+x2+x3+x4+x5+βHη3x9KV+βHη4x10KV,λR=βRx8x6+x7+x8+ξ1x9KV.

We choose βH as the bifurcation parameter by setting R0 = 1. To do this, we let βRβH which implies that βR = τβH for some τ > 0. Then from the value of R0 we get

βH=βH=2βH1+βH4+(βH1βH4)2+4βH2βH3, (A.2)

where

βH1=KVθ2(θ2+θ3)μ1(η2(δ+ζ2+μ1)νψ1(1+ν)η1(ζ1+μ1)ψ1)KVθ2(θ2+θ3)μ1(ζ1+μ1)(δ+ζ2+μ1)(μ1+ψ1)+π1(η3θ2+η4θ3)((δ+ζ2+μ1)νψ1φ1(1+ν)(ζ1+μ1)φ2ψ1)KVθ2(θ2+θ3)μ1(ζ1+μ1)(δ+ζ2+μ1)(μ1+ψ1),βH2=π1KVθ2(θ2+θ3)μ2+π2η3θ2+η4θ3φ3ψ2KVπ2θ2(θ2+θ3)μ1ρ+ψ2μ2+ρ+ψ2,βH3=π2τξ1δ+ζ2+μ1νψ1φ1(1+ν)ζ1+μ1φ2ψ1KV(θ2+θ3)ζ1+μ1δ+ζ2+μ1μ2μ1+ψ1,βH4=τKV(θ2+θ3)μ2+π2ξ1φ3ψ2KV(θ2+θ3)μ2ρ+ψ2μ2+ρ+ψ2.

The Jacobian of system (8) evaluated at the DFE E0 with the bifurcation parameter βH donated by JE0 is given as

μ10βHη2βHη1000βHμ2π1μ1π2βHη3π1μ1KVβHη4π1μ1KV0j22βHη2βHη1000βHμ2π1μ1π2βHη3π1μ1KVβHη4π1μ1KV0νψ1j3300000000(1ν)ψ10j4400000000ζ1ζ2μ10000000000(ρ+μ2)0τβHτβHξ1π2μ2KV0000000j77τβHτβHξ1π2μ2KV0000000ψ2j880000φ1φ2000φ3(θ2+θ3)000000000θ3θ2.

where

j22=(ψ1+μ1),j33=(ζ1+μ1),j44=(δ+ζ2+μ1),j77=(ψ2+ρ+μ2),j88=(ρ+μ2).

A right eigenvector associated with the zero eigenvalue is given by

w=(w1,w2,w3,w4,w5,w6,w7,w8,w9,w10)T.

We get it from the following equations:

μ1w1βHη2w3βHη1w4μ2π1μ1π2βHw8βHη3π1μ1KVw9βHη4π1μ1KVw10=0(ψ1+μ1)w2+βHη2w3+βHη1w4+μ2π1μ1π2βHw8+βHη3π1μ1KVw9+βHη4π1μ1KVw10=0νψ1w2(ζ1+μ1)w3=0(1ν)ψ1w2(δ+ζ2+μ1)w4=0ζ1w3+ζ2w4μ1w5=0(ρ+μ2)w6τβHw8τβHξ1π2μ2KVw9=0(ψ2+ρ+μ2)w7+τβHw8+τβHξ1π2μ2KVw9=0ψ2w7(ρ+μ2)w8=0φ1w3+φ2w4+φ3w8(θ2+θ3)w9=0θ3w9θ2w10=0 (A.3)

The solution to (A.3) gives

w1=βHη2w3μ1βHη1w4μ1βHμ2π1μ12π2w8βHη3π1μ12KVw9βHη4π1μ12KVw10,w2=w2>0,w3=νψ1w2ζ1+μ1,w4=(1ν)ψ1w2δ+ζ2+μ1,w5=ζ1w3+ζ2w4μ1,w6=τβHw8ρ+μ2τβHξ1π2μ2KV(ρ+μ2)w9,w7=τβHw8ψ2+ρ+μ2+τβHξ1π2μ2KV(ψ2+ρ+μ2)w9,w8=ψ2w7ρ+μ2,w9=φ1w3+φ2w4+φ3w8(θ2+θ3),w10=θ3w9θ2. (A.4)

Similarly, a left eigenvector (associated with the zero eigenvalue) given by

v=(v1,v2,v3,v4,v5,v6,v7,v8,v9,v10)T,

which satisfies v.w = 1 is obtained by the transpose of the matrix JE0 which is

μ10000000000j22Tνψ1(1ν)ψ1000000βHη2βHη2j33T0ζ1000φ10βHη1βHη10j44Tζ2000φ200000μ10000000000(ρ+μ2)0000000000j77Tψ200βHμ2π1μ1π2βHμ2π1μ1π2000τβHτβHj88Tφ30βHη3π1μ1KVβHη3π1μ1KV000τβHξ1π2μ2KVτβHξ1π2μ2KV0(θ2+θ3)θ3βHη4π1μ1KVβHη4π1μ1KV0000000θ2.

where

j22T=(ψ1+μ1),j33T=(ζ1+μ1),j44T=(δ+ζ2+μ1),j77T=(ψ2+ρ+μ2),j88T=(ρ+μ2).

The system of equations obtained is given by

μ1v1=0(ψ1+μ1)v2+νψ1v3+(1ν)ψ1v4=0βHη2v1+βHη2v2(ζ1+μ1)v3+ζ1v5+φ1v9=0βHη1v1+βHη1v2(δ+ζ2+μ1)v4+ζ2v5+φ2v9=0μ1v5=0(ρ+μ2)v6=0(ψ2+ρ+μ2)v7+ψ2v8=0βHμ2π1μ1π2v1+βHμ2π1μ1π2v2τβHv6+τβHv7(ρ+μ2)v8+φ3v9=0βHη3π1μ1KVv1+βHη3π1μ1KVv2τβHξ1π2μ2KVv6+τβHξ1π2μ2KVv7(θ2+θ3)v9+θ3v10=0βHη4π1μ1KVv1+βHη4π1μ1KVv2θ2v10=0 (A.4)

Solving (A.4) gives

v1=0,v2=v2>0,v3=βHη2v2+φ1v9ζ1+μ1,v4=βHη1v2+φ2v9δ+ζ2+μ1,v5=0,v6=0,v7=ψ2v8ψ2+ρ+μ2,v8=τβHv7ρ+μ2+βHμ2π1v2μ1π2(ρ+μ2)+φ3v9ρ+μ2,v9=βHη3π1v2μ1KV(θ2+θ3)+τβHξ1π2v7μ2KV(θ2+θ3)+θ3v10θ2+θ3,v10=βHη4π1v2θ2μ1KV.

We use the property v.w = 1 to get

v1w1+v2w2+v3w3+v4w4+v5w5+v6w6+v7w7+v8w8+v9w9+v10w10=1.

Choosing w2 = 1 without loss of generality gives us

v2=11+(A3w3+A4w4+A7w7+A8w8+A9w9+A10w10)>0,

where

A3=βHη2+π1μ2φ1τβHθ2ξ1ψ2+η3θ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2+η4θ3ρ2+μ22+ρτβHψ2+μ22ρ+ψ2θ2μ1τπ2βHξ1φ3ψ2+KVθ2+θ3μ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2ζ1+μ1,A4=βHη1+π1μ2φ2τβHθ2ξ1ψ2+η3θ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2+η4θ3ρ2+μ22+ρτβHψ2+μ22ρ+ψ2θ2μ1τπ2βHξ1φ3ψ2+KVθ2+θ3μ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2δ+ζ2+μ1,A7=π1βHμ2KVθ2θ2+θ3μ2+π2η3θ2+η4θ3φ3ψ2π2θ2μ1τπ2βHξ1φ3ψ2KVθ2+θ3μ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2,A8=π1βHμ2KVθ2θ2+θ3μ2+π2η3θ2+η4θ3φ3ρ+μ2+ψ2π2θ2μ1τπ2βHξ1φ3ψ2KVθ2+θ3μ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2,A10=βHη4π1θ2μ1KV,A9=π1βHμ2τβHθ2ξ1ψ2+η3θ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2+η4θ3ρ2+μ22+ρτβHψ2+μ22ρ+ψ2θ2μ1τπ2βHξ1φ3ψ2+KVθ2+θ3μ2ρ2+μ22+ρτβHψ2+μ22ρ+ψ2.

This value of v2 and w2 satisfies the given property. We now calculate the second order partial derivatives of gi at the disease free equilibrium E0 to get

2g2x1x8=βHμ2π2,2g2x1x9=βHη3KV,2g2x1x10=βHη4KV,2g2x2x3=βHη2μ1π1,2g2x2x4=βHη1μ1π1,2g2x3x4=βHμ1(η1+η2)π1,2g2x3x5=βHη2μ1π1,2g2x3x3=2βHη2μ1π1,2g2x4x4=2βHη1μ1π1,2g2x4x5=βHη1μ1π1,2g2x6x8=βHπ1μ22π22μ1,2g2x7x8=βHπ1μ22π22μ1,2g2x8x8=2βHπ1μ22π22μ1,2g7x7x8=βHμ2π2,2g7x8x8=2βHμ2π2,2g7x6x9=βHξ1KV.

We now compute the values of a and b to get

a=k,i,j=110vkwiwj2gk(0,0)xixj=βHη3KVw9+βHη4KVw10v2w1+βHξ1KVv7w6w9,βHη2μ1π1w2+w5+2w3+w4v2w3βHμ2π2w7+2w8v7w8,w7+2w8v2w8βHη1μ1π1w2+w3+2w4+w5v2w4,+βHμ2π2w1v2w1βHπ1μ22π22μ1w6v2w8, (A.5)

and

b=k,i=110vkwi2gk(0,0)xiβH=v2w3η2+v2w4η1+v2w8π1μ2π2μ1+v2w9π1η3μ1KV+v2w10π1η4μ1KV+v7w8+v7w9π2ξ1μ2KV>0. (A.6)
  • (i)

    If βHμ2π2w1v2w1<βHπ1μ22π22μ1w6v2w8 and b > 0, then system (5) will undergo a forward bifurcation at R0 = 1.

  • (ii)

    If Bwv<βHμ2π2w1v2w1βHπ1μ22π22μ1w6v2w8, and b > 0, then system (5) will undergo a backward bifurcation at R0 = 1, where

Bwv=βHη3KVw9+βHη4KVw10v2w1+βHξ1KVv7w6w9βHη2μ1π1w2+w5+2w3+w4v2w3,βHμ2π2w7+2w8v7w8w7+2w8v2w8βHη1μ1π1w2+w3+2w4+w5v2w4. (A.6)

References

  1. Abdulhamid A., Hussaini N., Musa S.S., He D. Mathematical analysis of lassa fever epidemic with effects of environmental transmission. Results in Physics. 2022;35 [Google Scholar]
  2. ACDC Lassa fever. Report on lassa fever: Centre for disease control and prevention. 2018. https://africacdc.org/disease/lassa-fever/ Retrieved on 21-04-2021 from.
  3. Akhmetzhanov A.R., Asai Y., Nishiura H. Quantifying the seasonal drivers of transmission for lassa fever in Nigeria. Philosophical Transactions of the Royal Society B. 2019;374 doi: 10.1098/rstb.2018.0268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bausch D.G., Hadi C.M., Khan S.H., Lertora J.J. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for lassa fever. Clinical Infectious Diseases. 2010;51:1435–1441. doi: 10.1086/657315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blower S.M., Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: An hiv model, as an example. International Statistical Review/Revue Internationale de Statistique. 1994:229–243. [Google Scholar]
  6. Castillo-Chavez C., Feng Z., Huang W., et al. On the computation of ro and its role on. Mathematical approaches for emerging and reemerging infectious diseases: An Introduction. 2002;1:229. [Google Scholar]
  7. Castillo-Chavez C., Song B. Dynamical models of tuberculosis and their applications. Mathematical Biosciences and Engineering. 2004;1:361. doi: 10.3934/mbe.2004.1.361. [DOI] [PubMed] [Google Scholar]
  8. CDC Lassa fever transmission. Report on viral hemorrhagic fevers: US department of health and human services. 2014. https://www.cdc.gov/vhf/lassa/transmission/index.html from.
  9. Chitnis N., Hyman J.M., Cushing J.M. Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model. Bulletin of Mathematical Biology. 2008;70:1272–1296. doi: 10.1007/s11538-008-9299-0. [DOI] [PubMed] [Google Scholar]
  10. Control P.P. How fast do mice multiply in your home? Preventive pest control. 2018. https://www.preventivepesthouston.com/blog/2018/may/how-fast-do-mice-multiply-in-your-home-/ Retrieved on 21-02-2022 from.
  11. Davies J., Lokuge K., Glass K. Routine and pulse vaccination for lassa virus could reduce high levels of endemic disease: A mathematical modelling study. Vaccine. 2019;37:3451–3456. doi: 10.1016/j.vaccine.2019.05.010. [DOI] [PubMed] [Google Scholar]
  12. Fichet-Calvet E., Becker-Ziaja B., Koivogui L., Günther S. Lassa serology in natural populations of rodents and horizontal transmission. Vector Borne and Zoonotic Diseases. 2014;14:665–674. doi: 10.1089/vbz.2013.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Freedman H.I., Ruan S., Tang M. Uniform persistence and flows near a closed positively invariant set. Journal of Dynamics and Differential Equations. 1994;6:583–600. [Google Scholar]
  14. Gibb R., Moses L.M., Redding D.W., Jones K.E. Understanding the cryptic nature of lassa fever in west africa. Pathogens and Global Health. 2017;111:276–288. doi: 10.1080/20477724.2017.1369643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gonzalez S.G. Lassa fever. MedicineNet. 2020. https://www.medicinenet.com/lassa_fever/article.htm Retrieved on 21-04-2021 from.
  16. Ibrahim M.A., Dénes A. A mathematical model for lassa fever transmission dynamics in a seasonal environment with a view to the 2017–20 epidemic in Nigeria. Nonlinear Analysis: Real World Applications. 2021;60 [Google Scholar]
  17. Lakshmikantham V., Leela S., Martynyuk A.A. Springer; 1989. Stability analysis of nonlinear systems. [Google Scholar]
  18. Ledder G. Scaling for dynamical systems in biology. Bulletin of Mathematical Biology. 2017;79:2747–2772. doi: 10.1007/s11538-017-0339-5. [DOI] [PubMed] [Google Scholar]
  19. Lehmann C., Kochanek M., Abdulla D., Becker S., Böll B., Bunte A., Cadar D., Dormann A., Eickmann M., Emmerich P., et al. Control measures following a case of imported lassa fever from Togo, north rhine westphalia, Germany, 2016. Euro Surveillance. 2017;22:17–88. doi: 10.2807/1560-7917.ES.2017.22.39.17-00088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Li M.Y., Muldowney J.S. A geometric approach to global-stability problems. SIAM Journal on Mathematical Analysis. 1996;27:1070–1083. [Google Scholar]
  21. Lo Iacono G., Cunningham A.A., Fichet-Calvet E., Garry R.F., Grant D.S., Khan S.H., Leach M., Moses L.M., Schieffelin J.S., Shaffer J.G., et al. Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: The case of lassa fever. PLoS Neglected Tropical Diseases. 2015;9:e3398. doi: 10.1371/journal.pntd.0003398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marino S., Hogue I.B., Ray C.J., Kirschner D.E. A methodology for performing global uncertainty and sensitivity analysis in systems biology. Journal of Theoretical Biology. 2008;254:178–196. doi: 10.1016/j.jtbi.2008.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mikucki M.A. Colorado State University; 2012. Sensitivity analysis of the basic reproduction number and other quantities for infectious disease models. Ph.D. thesis. [Google Scholar]
  24. Moghadas S.M., Gumel A.B., McLeod R.G., Gordon R. Could condoms stop the aids epidemic? Journal of Theoretical Medicine. 2003;5:171–181. [Google Scholar]
  25. Muldowney J.S. Compound matrices and ordinary differential equations. Rocky Mountain Journal of Mathematics. 1990:857–872. [Google Scholar]
  26. Musa S.S., Yusuf A., Abdullahi Z.U., Adamu L., Mustapha U.T., He D. 2022. Unravelling the dynamics of lassa fever transmission with differential infectivity: Modeling analysis and control strategies. [DOI] [PubMed] [Google Scholar]
  27. Musa S.S., Zhao S., Gao D., Lin Q., Chowell G., He D. Mechanistic modelling of the large-scale lassa fever epidemics in Nigeria from 2016 to 2019. Journal of Theoretical Biology. 2020;493 doi: 10.1016/j.jtbi.2020.110209. [DOI] [PubMed] [Google Scholar]
  28. NCDC An update of lassa fever outbreak in Nigeria. Weekly Report on Lassa fever outbreak in Nigeria. 2021. https://www.ncdc.gov.ng/diseases/sitreps/ Retrieved on 19-11-2021 from.
  29. NCDC An update of lassa fever outbreak in Nigeria. Weekly Report on Lassa fever outbreak in Nigeria. 2022. https://www.ncdc.gov.ng/diseases/sitreps/ Retrieved on 15-03-2022 from.
  30. Newman T. 2018. Everything you need to know about lassa fever. MedicalNewsToday.https://www.medicalnewstoday.com/articles/306886 from. [Google Scholar]
  31. NICD Lassa fever disease. Lassa fever report: Division of the national health laboratory service. 2020. https://www.nicd.ac.za/diseases-a-z-index/lassa-fever/ Retrieved on 21-04-2021 from.
  32. Obabiyi O., Onifade A.A. Mathematical model for lassa fever transmission dynamics with variable human and reservoir population. International Journal of Differential Equations and Applications. 2017;16 [Google Scholar]
  33. Ojo M.M., Gbadamosi B., Benson T.O., Adebimpe O., Georgina A. Modeling the dynamics of lassa fever in Nigeria. Journal of the Egyptian Mathematical Society. 2021;29:1–19. [Google Scholar]
  34. Onah I.S., Collins O.C., Madueme P.G.U., Mbah G.C.E. Dynamical system analysis and optimal control measures of lassa fever disease model. International Journal of Mathematics and Mathematical Sciences. 2020;2020 [Google Scholar]
  35. Onuorah M., Ojo M., Usman D., Ademu A. Basic reproductive number for the spread and control of lassa fever. International Journal of Mathematics Trends and Technology. 2016;30:1–7. [Google Scholar]
  36. Ossai E.N., Onwe O.E., Okeagu N.P., Ugwuoru A.L., Eze T.K., Nwede A.S. Knowledge and preventive practices against lassa fever among heads of households in abakaliki metropolis, southeast Nigeria: A cross-sectional study. Proceedings of Singapore Healthcare. 2020;29:73–80. [Google Scholar]
  37. Peter O.J., Abioye A.I., Oguntolu F.A., Owolabi T.A., Ajisope M.O., Zakari A.G., Shaba T.G. Modelling and optimal control analysis of lassa fever disease. Informatics in Medicine Unlocked. 2020;20 [Google Scholar]
  38. Punch Lassa fever kills four doctors, infects 38 health workers. 2022. https://punchng.com/lassa-fever-kills-four-doctors-infects-38-health-workers/ PUNCH Newspaper, Retrieved on 15-03-2022 from.
  39. Richmond J.K., Baglole D.J. Lassa fever: Epidemiology, clinical features, and social consequences. BMJ. 2003;327:1271–1275. doi: 10.1136/bmj.327.7426.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sabeti P.C. Cell; 2015. Clinical sequencing uncovers origins and evolution of lassa virus. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Saltelli A., Ratto M., Andres T., Campolongo F., Cariboni J., Gatelli D., Saisana M., Tarantola S. John Wiley & Sons; 2008. Global sensitivity analysis: The primer. [Google Scholar]
  42. Saltelli A., Tarantola S., Campolongo F., Ratto M., et al. 2004. Sensitivity analysis in practice: A guide to assessing scientific models. (Chichester, England) [Google Scholar]
  43. Srivastava A., Srivastava P.K., et al. Nonlinear dynamics of a siri model incorporating the impact of information and saturated treatment with optimal control. The European Physical Journal Plus. 2022;137:1–25. doi: 10.1140/epjp/s13360-022-03201-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stephenson E.H., Larson E.W., Dominik J.W. Effect of environmental factors on aerosol-induced lassa virus infection. Journal of Medical Virology. 1984;14:295–303. doi: 10.1002/jmv.1890140402. [DOI] [PubMed] [Google Scholar]
  45. Tewogbola, P., Aung, N., . Lassa fever: History, causes, effects, and reduction strategies. Virus 2, 16.
  46. Trends M. 2021. Nigeria life expectancy 1951-2021. Macro Trends.https://www.macrotrends.net/countries/NGA/nigeria/life-expectancy Retrieved on 19-11-2021 from. [Google Scholar]
  47. Turányi T. Sensitivity analysis of complex kinetic systems. tools and applications. Journal of Mathematical Chemistry. 1990;5:203–248. [Google Scholar]
  48. Van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Mathematical Biosciences. 2002;180:29–48. doi: 10.1016/s0025-5564(02)00108-6. [DOI] [PubMed] [Google Scholar]
  49. Velasco-Hernandez J.X., Hsieh Y.H. Modelling the effect of treatment and behavioral change in hiv transmission dynamics. Journal of Mathematical Biology. 1994;32:233–249. doi: 10.1007/BF00163880. [DOI] [PubMed] [Google Scholar]
  50. WHO Lassa fever. WHO factsheets. 2017. http://www.who.int/mediacentre/factsheets/fs179/en/ from.
  51. WHO . WHO Factsheets; 2020. Lassa fever-Nigeria.https://www.who.int/csr/don/20-february-2020-lassa-fever-nigeria/en/ Retrieved on 21-04-2021 from. [Google Scholar]
  52. WHO . World Health Organization; 2021. Stakeholders shore up sensitization campaign to curb lassa fever outbreak in edo state.https://www.afro.who.int/news/stakeholders-shore-sensitization-campaign-curb-lassa-fever-outbreak-edo-state Retrieved on 19-11-2021 from. [Google Scholar]
  53. Yun N.E., Walker D.H. Pathogenesis of lassa fever. Viruses. 2012;4:2031–2048. doi: 10.3390/v4102031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zhao S., Musa S.S., Fu H., He D., Qin J. Large-scale lassa fever outbreaks in Nigeria: Quantifying the association between disease reproduction number and local rainfall. Epidemiology and Infection. 2020;148 doi: 10.1017/S0950268819002267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Disease Modelling are provided here courtesy of KeAi Publishing

RESOURCES